SEARCH

SEARCH BY CITATION

References

  • ADAMS, I.B., COMPTON, D.R. & MARTIN, B.R. (1998). Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther., 284, 12091217.
  • BARTHO, L., LENARD, L., PATACCHINI, R., HALMAI, V., WILHELM, M., HOLZER, P. & MAGGI, C.A. (1999). Tachykinin receptors are involved in the ‘local efferent' motor response to capsaicin in the guinea-pig small intestine and oesophagus. Neuroscience, 90, 221228.
  • BEVAN, S., HOTHI, S., HUGHES, G., JAMES, I.F., RANG, H.P., SHAH, K., WALPOLE, C.S. & YEATS, J.C. (1992). Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol., 107, 544552.
  • COUTTS, A.A. & PERTWEE, R.G. (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br. J. Pharmacol., 121, 15571566.
  • DI MARZO, V., MELCK, D., BISOGNO, T. & DEPETROCELLIS, L. (1998). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci., 21, 521528.
  • FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Catecholamines, Handb. Exp. Pharmakol., Vol. 33, ed. Blaschko, H., Muscholl, E. pp. 283335. Berlin: Springer-Verlag.
  • HOLZER, P. (1991). Capsaicin:cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol. Rev., 43, 143201.
  • HOLZER, P. & HOLZER-PETSCHE, U. (1997). Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol. Ther., 73, 173217.
  • IZZO, A.A., MASCOLO, N., BORRELLI, F. & CAPASSO, F. (1998). Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors. Br. J. Pharmacol., 124, 13631368.
  • JERMAN, J.C., BROUGH, S.J., PRINJHA, R., HARRIES, M.H., DAVIS, J.B. & SMART, D. (2000). Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology. Br. J. Pharmacol., 130, 916922.
  • KILBINGER, H. & WESSLER, I. (1980). Inhibition by acetylcholine of stimulation-evoked release of [3H]acetylcholine from the guinea-pig myenteric plexus. Neuroscience, 5, 13311340.
  • MANG, C.F., ERBELDING, D. & KILBINGER, H. (2001). Differential effects of anandamide in basal and evoked release of acetylcholine (ACh) from guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol., 363, R 24.
  • MANG, C.F., GEBER, C. & KILBINGER, H. (2000). Effects of capsaicin on acetylcholine (ACh) release from guinea-pig myenteric plexus. Naunyn-Schmiedeberg's Arch. Pharmacol., 361, R 22.
  • PERTWEE, R.G. (1999). Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sci., 65, 597605.
  • PERTWEE, R.G., FERNANDO, S.R., GRIFFIN, G., ABADJI, V. & MAKRIYANNIS, A. (1995a). Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol., 272, 7378.
  • PERTWEE, R.G., FERNANDO, S.R., NASH, J.E. & COUTTS, A.A. (1996). Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 21992205.
  • PERTWEE, R., GRIFFIN, G., FERNANDO, S., LI, X., HILL, A. & MAKRIYANNIS, A. (1995b). AM630, a competitive cannabinoid receptor antagonist. Life Sci., 56, 19491955.
  • RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240244.
  • RINALDI-CARMONA, M., BARTH, F., MILLAN, J., DEROCQ, J.M., CASELLAS, P., CONGY, C., OUSTRIC, D., SARRAN, M., BOUABOULA, M., CALANDRA, B., PORTIER, M., SHIRE, D., BRELIERE, J.C. & LE FUR, G.L. (1998). SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644650.
  • SCHWÖRER, H., SCHMIDT, W.E., KATSOULIS, S. & CREUTZFELDT, W. (1991). Calcitonin gene-related peptide (CGRP) modulates cholinergic neurotransmission in the small intestine of man, pig and guinea-pig via presynaptic CGRP receptors. Regul. Pept., 36, 345358.
  • SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227230.
  • SZALLASI, A. & BLUMBERG, P.M. (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev., 51, 159211.
  • WELCH, S.P., HUFFMAN, J.W. & LOWE, J. (1998). Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J. Pharmacol. Exp. Ther., 286, 13011308.
  • ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H.H., SORGARD, M., DIMARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452457.